BERGER FRANKLIN M purchased 10K shares of RETENSION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $120.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/13/2026ACC: 0001213900-26-109155
Director
Since Oct 2026
+10K
Net shares
Net buyer
$120.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
22.52K acquired · 12.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.52K
Price / share
—
Trade value
—
% of position
New position
10/13/2026
0.00→12.52K
Common Stock
Indirect
Shares
+10K
Price / share
$12.00
Trade value
$120K
% of position
New position
10/13/2026
0.00→10K
Total
Net shares
+22.52K
Net value
$120K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/13/2026 | C · Conversion | +12.52K | — | — | New position | 0.00 | 12.52K |
| Common Stock Indirect | 10/13/2026 | P · Purchase | +10K | $12.00 | $120K | New position | 0.00 | 10K |
| Total | +22.52K | $120K | ||||||
Derivative Transactions1
Series B Convertible Preferred Stock
Direct
Converts to
Common Stock
12.52K shares
Shares
−12.52K
Strike price
Held after
0.00
Exercisable
—
10/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred Stock Direct | Common Stock12.52K shares | 10/13/2026 | C · Conversion | −12.52K | — | 0.00 |